Fibryga (fibrinogen concentrate (human)) / Octapharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fibryga (fibrinogen concentrate (human)) / Octapharma
NCT01575756: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

Completed
2
22
US, Europe, RoW
Octafibrin, Plasma derived fibrinogen concentrate, Haemocomplettan® P or RiaSTAPTM
Octapharma
Congenital Fibrinogen Deficiency, Afibrinogenemia
01/15
01/15
2016-003749-27: Fibrinogen (blood protein) supplementation in patients that have developed fibrinogen deficiency during surgery.

Ongoing
2
55
Europe
Octafibrin, Cryoprecipitate, Powder for solution for injection, Concentrate for solution for injection/infusion
Octapharma AG
The sequence of events culminating in Pseudomyxoma peritonei (PMP) is thought to involve growth of an appendiceal adenoma with distension of the appendix by mucus and mucinous tumour cells. The appendix eventually ruptures. Patients undergoing the PMP surgery develop a coagulopathy predominantly characterised by reduced levels of fibrinogen, resulting in reduced whole blood clot firmness., Surgery performed on a cancer (tumour) in the appendix, causes decreased levels of blood clotting factor (fibrinogen)., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
 
 
2011-002403-15: A controlled, randomised, study investigating the pharmacokineticproperties (to see how active the study drug is in your blood and how long it takes for the study drug to get out of your blood) , surrogate efficacy and safety of Octafibrin compared to Haemocomplettan® P/ RiaSTAPTM in subjects with congenital fibrinogen deficiency

Completed
1/2
18
Europe
octafibrin, Haemocomplettan® P, Powder for solution for injection, Haemocomplettan® P
OCTAPHARMA AG, OCTAPHARM
congenital fibrinogen deficiency, deficency of fibrinogen in human plasma, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 

Download Options